Mpox Vaccine Proves Highly Successful; Resistance To Cefiderocol Is Increasing
Read recent pharmaceutical developments in KFF Health News' Prescription Drug Watch roundup.
ScienceDaily:
New Study Shows Effectiveness Of Mpox Vaccine
A new international study has shown mpox (formerly known as monkeypox) infections to be less severe among those who are vaccinated or had a previous infection in 2022, underlining the importance and effectiveness of vaccination. (Queen Mary University of London, 9/5)
CIDRAP:
High Resistance To Last-Resort Antibiotic Observed In Some Clinical Isolates
A systematic review and meta-analysis found resistance to cefiderocol was low overall but "alarmingly high" among certain types of carbapenem-resistant bacteria, Greek researchers reported late last week in Clinical Microbiology and Infection. (Dall, 9/5)
CIDRAP:
Study Finds Higher Rate Of Inappropriate Antibiotic Prescribing In Winter
A study conducted within a university health system found a greater proportion of inappropriate antibiotic prescribing for respiratory conditions during the winter months, researchers reported today in Antimicrobial Stewardship & Healthcare Epidemiology. (Dall, 9/5)
ScienceDaily:
New Genes And Natural Toxins Offer Hope For Cancer Patients Unresponsive To Chemotherapy
Scientists have discovered two new genes that cause head and neck cancer patients to be resistant to chemotherapy, and that silencing either gene can make cancer cells previously unresponsive to chemotherapy subsequently respond to it. (Queen Mary University of London, 9/4)
